US Market Report Suite for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedSuite - Product Image

US Market Report Suite for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedSuite

  • ID: 4457260
  • Report
  • Region: United States
  • 446 pages
  • iData Research
1 of 4

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Nova Biomedical
  • Roche
  • MORE
Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost. The U.S. diabetes monitoring, treatment and drug delivery market increased in value in 2016 and growth is expected to persist over the forecast period. Growth will be driven by the increasing prevalence of diabetes in the U.S. and technological advancements made in certain segments, particularly insulin pumps and continuous glucose monitoring (CGM).

Limitations to market growth include pricing pressure due to recent CMS reimbursement changes and the negative impact on the overall blood glucose monitoring market. The recent influx of low-price competitors in the blood glucose test strip segment has also placed downward pressure on prices and resulted in market value contractions despite the growing volume and increasing number of diabetics testing their blood glucose levels.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Nova Biomedical
  • Roche
  • MORE
Executive Summary
U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History

1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. Disease Overview
2.1 Introduction
2.1.1 Types of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated With Type 1 and Type 2 Diabetes
2.1.4 Signs and Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems

3. U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview
3.1 Market Overview
3.2 Trend Analysis
3.3 Drivers and Limiters
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers and Acquisitions

4. Blood Glucose Meter Market
4.1 Introduction
4.2 Market Overview
4.3 Market Analysis and Forecast
4.3.1 Total Blood Glucose Meter Market
4.3.1.1 Personal Blood Glucose Meter Market
4.3.1.2 Professional Blood Glucose Meter Market
4.4 Drivers and Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis

5. Blood Glucose Test Strip Market
5.1 Introduction
5.2 Market Overview
5.3 Market Analysis and Forecast
5.3.1 Total Blood Glucose Test Strip Market
5.3.2 Total Personal Blood Glucose Test Strip Market
5.3.2.1 Medicare/Medicaid Blood Glucose Test Strip Market
5.3.2.2 Managed Care Blood Glucose Test Strip Market
5.3.2.3 Cash Blood Glucose Test Strip Market
5.3.3 Professional Blood Glucose Test Strip Market
5.4 Drivers and Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

6. Lancet and Lancing Device Market
6.1 Introduction
6.2 Market Overview
6.3 Market Analysis and Forecast
6.3.1 Total Lancet and Lancing Device Market
6.3.1.1 Personal Lancet and Lancing Device Market
6.3.1.2 Professional Lancet and Lancing Device Market
6.4 Drivers and Limiters
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

7. Continuous Glucose Monitoring Market
7.1 Introduction
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Total Personal Continuous Glucose Monitoring Market
7.3.1.1 Personal Continuous Glucose Monitoring Receiver Market
7.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market
7.3.1.3 Personal Continuous Glucose Monitoring Sensor Market
7.3.2 Total Professional Continuous Glucose Monitoring Market
7.3.2.1 Professional Continuous Glucose Monitoring System Market
7.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market
7.3.2.3 Professional Continuous Glucose Monitoring Sensor Market
7.3.3 Emerging Markets: Non-Invasive Cgm
7.4 Drivers and Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis

8. Insulin Market
8.1 Introduction
8.1.1 Insulin Types
8.1.1.1 Rapid-Acting Insulin Analogs
8.1.1.2 Regular Human Insulin
8.1.1.3 Intermediate-Acting Human Insulin
8.1.1.4 Long-Acting Insulin Analogs
8.1.1.5 Ultra-Long-Acting Insulin Analogs
8.1.1.6 Premixed Insulin
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Total Insulin Market
8.3.1.1 Long-Acting Insulin Market
8.3.1.2 Rapid-Acting Insulin Market
8.3.1.3 Premixed Insulin Market
8.3.1.4 Human Insulin Market
8.4 Drivers and Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis

9. Insulin Pen Market
9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Prefilled Insulin Pen Market
9.3.2 Insulin Pen Cartridge Market
9.3.3 Reusable Insulin Pen Market
9.3.4 Total Insulin Pen Needle Market
9.3.4.1 Conventional Insulin Pen Needle Market
9.3.4.2 Safety Insulin Pen Needle Market
9.4 Drivers and Limiters
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 Competitive Market Share Analysis

10. Insulin Syringe Market
10.1 Introduction
10.2 Market Overview
10.3 Market Analysis and Forecast
10.3.1 Total Insulin Syringe Market
10.3.1.1 Conventional Insulin Syringe Market
10.3.1.2 Safety Insulin Syringe Market
10.4 Drivers and Limiters
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 Competitive Market Share Analysis

11. Insulin Pump Market
11.1 Introduction
11.1.1 Traditional Insulin Pumps
11.1.2 Patch Insulin Pumps
11.1.3 Simple Insulin Pumps
11.2 Market Overview
11.3 Market Analysis and Forecast
11.3.1 Total Traditional Insulin Pump Market
11.3.1.1 Traditional Insulin Pump Market
11.3.1.2 Infusion Set Market
11.3.1.3 Pump Reservoir Market
11.3.2 Total Patch Insulin Pump Market
11.3.2.1 Patch Pump System Market
11.3.2.2 Insulin Pod Market
11.3.3 Simple Insulin Pump Market
11.4 Drivers and Limiters
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 Competitive Market Share Analysis

Abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Sanofi
  • Novo Nordisk
  • Eli Lilly
  • Medtronic
  • Johnson & Johnson
  • Becton Dickinson
  • Abbott
  • Roche
  • DexCom
  • Ascensia
  • Insulet
  • Trividia Health
  • Tandem
  • Nova Biomedical
  • Valeritas
Please Note: Not all companies are currently active in every segment or sub-report from this suite.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll